GILD logo

Gilead Sciences (GILD) Operating profit

annual operating profit:

$10.51B+$1.70B(+19.24%)
December 31, 2024

Summary

  • As of today (April 16, 2025), GILD annual operating income is $10.51 billion, with the most recent change of +$1.70 billion (+19.24%) on December 31, 2024.
  • During the last 3 years, GILD annual operating profit has fallen by -$352.00 million (-3.24%).
  • GILD annual operating profit is now -52.67% below its all-time high of $22.19 billion, reached on December 31, 2015.

Performance

GILD Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDincome statement metrics

quarterly operating profit:

$2.44B-$702.00M(-22.34%)
December 31, 2024

Summary

  • As of today (April 16, 2025), GILD quarterly operating income is $2.44 billion, with the most recent change of -$702.00 million (-22.34%) on December 31, 2024.
  • Over the past year, GILD quarterly operating profit has dropped by -$702.00 million (-22.34%).
  • GILD quarterly operating profit is now -56.57% below its all-time high of $5.62 billion, reached on December 31, 2015.

Performance

GILD quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDincome statement metrics

TTM operating profit:

$8.07B+$433.00M(+5.67%)
December 31, 2024

Summary

  • As of today (April 16, 2025), GILD TTM operating income is $8.07 billion, with the most recent change of +$433.00 million (+5.67%) on December 31, 2024.
  • Over the past year, GILD TTM operating profit has increased by +$433.00 million (+5.67%).
  • GILD TTM operating profit is now -63.62% below its all-time high of $22.19 billion, reached on December 31, 2015.

Performance

GILD TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherGILDincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

GILD Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+19.2%-22.3%+5.7%
3 y3 years-3.2%-22.3%+5.7%
5 y5 years+12.5%-22.3%+5.7%

GILD Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-4.3%+19.2%-52.4%+1378.0%-37.7%+25.6%
5 y5-year-4.3%+19.2%-52.4%+1378.0%-37.7%+25.6%
alltimeall time-52.7%+8804.2%-56.6%+1378.0%-63.6%+6789.9%

Gilead Sciences Operating profit History

DateAnnualQuarterlyTTM
Dec 2024
$10.51B(+19.2%)
$2.44B(-22.3%)
$8.07B(+5.7%)
Sep 2024
-
$3.14B(+17.2%)
$7.64B(+6.0%)
Jun 2024
-
$2.68B(-1503.7%)
$7.21B(+12.1%)
Mar 2024
-
-$191.00M(-109.5%)
$6.43B(-27.0%)
Dec 2023
$8.81B(-19.7%)
$2.01B(-26.0%)
$8.81B(-26.1%)
Sep 2023
-
$2.71B(+42.7%)
$11.92B(-4.6%)
Jun 2023
-
$1.90B(-13.0%)
$12.50B(-3.5%)
Mar 2023
-
$2.19B(-57.4%)
$12.95B(+18.0%)
Dec 2022
$10.97B(+1.1%)
$5.13B(+56.0%)
$10.97B(+47.1%)
Sep 2022
-
$3.29B(+39.3%)
$7.46B(-7.7%)
Jun 2022
-
$2.36B(+1050.7%)
$8.08B(-0.3%)
Mar 2022
-
$205.00M(-87.3%)
$8.11B(-25.3%)
Dec 2021
$10.86B(+9.4%)
$1.61B(-58.8%)
$10.85B(-9.2%)
Sep 2021
-
$3.91B(+63.9%)
$11.96B(+6.5%)
Jun 2021
-
$2.38B(-19.2%)
$11.22B(+8.1%)
Mar 2021
-
$2.95B(+8.7%)
$10.38B(+4.6%)
Dec 2020
$9.93B(+6.3%)
$2.71B(-14.4%)
$9.93B(+9.0%)
Sep 2020
-
$3.17B(+105.8%)
$9.11B(+8.1%)
Jun 2020
-
$1.54B(-38.3%)
$8.42B(-11.1%)
Mar 2020
-
$2.50B(+32.0%)
$9.47B(+2.8%)
Dec 2019
$9.34B(+0.4%)
$1.89B(-23.9%)
$9.21B(-3.7%)
Sep 2019
-
$2.49B(-4.2%)
$9.56B(-1.4%)
Jun 2019
-
$2.60B(+16.0%)
$9.70B(+3.4%)
Mar 2019
-
$2.24B(-0.2%)
$9.38B(+0.9%)
Dec 2018
$9.30B(-34.2%)
$2.24B(-14.5%)
$9.30B(-0.5%)
Sep 2018
-
$2.62B(+15.0%)
$9.35B(-11.3%)
Jun 2018
-
$2.28B(+5.9%)
$10.54B(-15.8%)
Mar 2018
-
$2.15B(-6.0%)
$12.51B(-11.4%)
Dec 2017
$14.12B(-19.9%)
$2.29B(-39.9%)
$14.12B(-11.0%)
Sep 2017
-
$3.81B(-10.4%)
$15.88B(-3.6%)
Jun 2017
-
$4.25B(+12.9%)
$16.46B(-1.7%)
Mar 2017
-
$3.77B(-6.9%)
$16.75B(-5.0%)
Dec 2016
$17.63B(-20.5%)
$4.04B(-8.0%)
$17.63B(-8.2%)
Sep 2016
-
$4.40B(-3.1%)
$19.21B(-5.8%)
Jun 2016
-
$4.54B(-2.4%)
$20.39B(-5.0%)
Mar 2016
-
$4.65B(-17.3%)
$21.47B(-3.2%)
Dec 2015
$22.19B(+45.4%)
$5.62B(+0.6%)
$22.19B(+6.2%)
Sep 2015
-
$5.58B(-0.6%)
$20.90B(+11.2%)
Jun 2015
-
$5.62B(+4.6%)
$18.80B(+6.8%)
Mar 2015
-
$5.37B(+24.0%)
$17.59B(+15.3%)
Dec 2014
$15.27B(+237.4%)
$4.33B(+24.4%)
$15.27B(+25.8%)
Sep 2014
-
$3.48B(-21.1%)
$12.13B(+23.8%)
Jun 2014
-
$4.41B(+45.0%)
$9.80B(+49.8%)
Mar 2014
-
$3.04B(+154.2%)
$6.54B(+44.6%)
Dec 2013
$4.52B(+12.8%)
$1.20B(+4.3%)
$4.52B(+2.0%)
Sep 2013
-
$1.15B(-0.5%)
$4.43B(+2.4%)
Jun 2013
-
$1.15B(+12.5%)
$4.33B(+2.2%)
Mar 2013
-
$1.03B(-7.4%)
$4.24B(+5.6%)
Dec 2012
$4.01B(+5.8%)
$1.11B(+6.0%)
$4.01B(+6.3%)
Sep 2012
-
$1.04B(-1.4%)
$3.77B(+1.1%)
Jun 2012
-
$1.06B(+32.4%)
$3.73B(+1.1%)
Mar 2012
-
$800.19M(-7.8%)
$3.69B(-2.7%)
Dec 2011
$3.79B(-4.4%)
$867.48M(-13.6%)
$3.79B(+1.0%)
Sep 2011
-
$1.00B(-1.3%)
$3.75B(+0.7%)
Jun 2011
-
$1.02B(+12.7%)
$3.73B(+0.7%)
Mar 2011
-
$901.97M(+8.8%)
$3.70B(-6.5%)
Dec 2010
$3.96B(+12.3%)
$829.38M(-15.3%)
$3.96B(-5.6%)
Sep 2010
-
$979.07M(-1.4%)
$4.20B(+2.1%)
Jun 2010
-
$992.63M(-14.5%)
$4.11B(+6.0%)
Mar 2010
-
$1.16B(+9.0%)
$3.88B(+10.0%)
Dec 2009
$3.53B(+31.2%)
$1.07B(+19.1%)
$3.53B(+11.2%)
Sep 2009
-
$894.41M(+17.5%)
$3.17B(+6.7%)
Jun 2009
-
$761.06M(-5.8%)
$2.97B(+5.1%)
Mar 2009
-
$808.32M(+13.7%)
$2.83B(+5.2%)
Dec 2008
$2.69B(+24.2%)
$711.15M(+2.5%)
$2.69B(+7.9%)
Sep 2008
-
$693.83M(+12.6%)
$2.49B(+6.3%)
Jun 2008
-
$616.37M(-7.7%)
$2.35B(+3.2%)
Mar 2008
-
$668.05M(+29.8%)
$2.27B(+5.0%)
Dec 2007
$2.16B
$514.49M(-5.9%)
$2.16B(+1.4%)
Sep 2007
-
$547.03M(+0.8%)
$2.14B(+6.7%)
DateAnnualQuarterlyTTM
Jun 2007
-
$542.85M(-3.1%)
$2.00B(+9.7%)
Mar 2007
-
$560.14M(+15.4%)
$1.82B(+11.5%)
Dec 2006
$1.64B(+47.4%)
$485.22M(+17.5%)
$1.64B(+8.3%)
Sep 2006
-
$413.11M(+13.1%)
$1.51B(+12.3%)
Jun 2006
-
$365.31M(-1.7%)
$1.35B(+7.0%)
Mar 2006
-
$371.65M(+3.3%)
$1.26B(+13.4%)
Dec 2005
$1.11B(+76.8%)
$359.84M(+45.0%)
$1.11B(+21.8%)
Sep 2005
-
$248.25M(-10.5%)
$910.22M(+10.2%)
Jun 2005
-
$277.50M(+24.2%)
$825.74M(+16.9%)
Mar 2005
-
$223.48M(+38.8%)
$706.44M(+12.6%)
Dec 2004
$627.39M(+90.2%)
$161.00M(-1.7%)
$627.39M(+13.2%)
Sep 2004
-
$163.77M(+3.5%)
$554.37M(+18.0%)
Jun 2004
-
$158.20M(+9.5%)
$469.77M(+12.0%)
Mar 2004
-
$144.42M(+64.2%)
$419.35M(+27.1%)
Dec 2003
$329.92M(+307.3%)
$87.98M(+11.1%)
$329.92M(+20.1%)
Sep 2003
-
$79.17M(-26.5%)
$274.79M(+18.7%)
Jun 2003
-
$107.77M(+95.9%)
$231.53M(+62.0%)
Mar 2003
-
$55.00M(+67.5%)
$142.95M(+76.5%)
Dec 2002
$81.01M(-167.1%)
$32.84M(-8.6%)
$81.01M(+248.5%)
Sep 2002
-
$35.92M(+87.1%)
$23.24M(-147.7%)
Jun 2002
-
$19.19M(-376.5%)
-$48.74M(-52.1%)
Mar 2002
-
-$6.94M(-72.1%)
-$101.83M(-15.6%)
Dec 2001
-$120.69M(+130.7%)
-$24.92M(-30.9%)
-$120.69M(+5.5%)
Sep 2001
-
-$36.07M(+6.4%)
-$114.42M(+15.2%)
Jun 2001
-
-$33.90M(+31.4%)
-$99.29M(+39.8%)
Mar 2001
-
-$25.80M(+38.3%)
-$71.03M(+43.0%)
Dec 2000
-$52.32M(+1.2%)
-$18.65M(-10.9%)
-$49.68M(+119.5%)
Sep 2000
-
-$20.94M(+271.6%)
-$22.63M(-31.2%)
Jun 2000
-
-$5.63M(+26.6%)
-$32.89M(-17.0%)
Mar 2000
-
-$4.45M(-153.0%)
-$39.62M(-23.4%)
Dec 1999
-$51.70M(-34.0%)
$8.40M(-126.9%)
-$51.72M(-36.2%)
Sep 1999
-
-$31.20M(+152.4%)
-$81.02M(+13.4%)
Jun 1999
-
-$12.36M(-25.3%)
-$71.42M(-9.4%)
Mar 1999
-
-$16.55M(-20.8%)
-$78.85M(+5.8%)
Dec 1998
-$78.30M(+8.6%)
-$20.90M(-3.2%)
-$74.50M(-23.4%)
Sep 1998
-
-$21.60M(+9.1%)
-$97.20M(+7.2%)
Jun 1998
-
-$19.80M(+62.3%)
-$90.70M(+25.4%)
Mar 1998
-
-$12.20M(-72.0%)
-$72.30M(+0.4%)
Dec 1997
-$72.10M(+99.7%)
-$43.60M(+188.7%)
-$72.00M(+76.9%)
Sep 1997
-
-$15.10M(+978.6%)
-$40.70M(+102.5%)
Jun 1997
-
-$1.40M(-88.2%)
-$20.10M(-41.9%)
Mar 1997
-
-$11.90M(-3.3%)
-$34.60M(-3.9%)
Dec 1996
-$36.10M(+12.8%)
-$12.30M(-323.6%)
-$36.00M(+51.9%)
Sep 1996
-
$5.50M(-134.6%)
-$23.70M(-39.4%)
Jun 1996
-
-$15.90M(+19.5%)
-$39.10M(+21.4%)
Mar 1996
-
-$13.30M(+34.3%)
-$32.20M(-15.5%)
Dec 1995
-$32.00M(-9.1%)
-
-
Sep 1995
-
-$9.90M(+10.0%)
-$38.10M(+5.5%)
Jun 1995
-
-$9.00M(-10.0%)
-$36.10M(+2.6%)
Mar 1995
-
-$10.00M(+8.7%)
-$35.20M(+2.6%)
Mar 1995
-$35.20M(+19.3%)
-
-
Dec 1994
-
-$9.20M(+16.5%)
-$34.30M(+4.9%)
Sep 1994
-
-$7.90M(-2.5%)
-$32.70M(+3.5%)
Jun 1994
-
-$8.10M(-11.0%)
-$31.60M(+7.8%)
Mar 1994
-$29.50M(+62.1%)
-$9.10M(+19.7%)
-$29.30M(+8.1%)
Dec 1993
-
-$7.60M(+11.8%)
-$27.10M(+11.5%)
Sep 1993
-
-$6.80M(+17.2%)
-$24.30M(+14.6%)
Jun 1993
-
-$5.80M(-15.9%)
-$21.20M(+16.5%)
Mar 1993
-$18.20M(+188.9%)
-$6.90M(+43.8%)
-$18.20M(-1.6%)
Dec 1992
-
-$4.80M(+29.7%)
-$18.50M(+40.2%)
Sep 1992
-
-$3.70M(+32.1%)
-$13.20M(+41.9%)
Jun 1992
-
-$2.80M(-61.1%)
-$9.30M(+47.6%)
Mar 1992
-$6.30M(+31.3%)
-$7.20M(-1540.0%)
-$6.30M(+57.5%)
Dec 1991
-
$500.00K(+150.0%)
-$4.00M(-9.1%)
Sep 1991
-
$200.00K(0.0%)
-$4.40M(-2.2%)
Jun 1991
-
$200.00K(-104.1%)
-$4.50M(-2.2%)
Mar 1991
-$4.80M
-$4.90M(-5000.0%)
-$4.60M(-1633.3%)
Dec 1990
-
$100.00K(0.0%)
$300.00K(+50.0%)
Sep 1990
-
$100.00K(0.0%)
$200.00K(+100.0%)
Jun 1990
-
$100.00K
$100.00K

FAQ

  • What is Gilead Sciences annual operating income?
  • What is the all time high annual operating profit for Gilead Sciences?
  • What is Gilead Sciences annual operating profit year-on-year change?
  • What is Gilead Sciences quarterly operating income?
  • What is the all time high quarterly operating profit for Gilead Sciences?
  • What is Gilead Sciences quarterly operating profit year-on-year change?
  • What is Gilead Sciences TTM operating income?
  • What is the all time high TTM operating profit for Gilead Sciences?
  • What is Gilead Sciences TTM operating profit year-on-year change?

What is Gilead Sciences annual operating income?

The current annual operating profit of GILD is $10.51B

What is the all time high annual operating profit for Gilead Sciences?

Gilead Sciences all-time high annual operating income is $22.19B

What is Gilead Sciences annual operating profit year-on-year change?

Over the past year, GILD annual operating income has changed by +$1.70B (+19.24%)

What is Gilead Sciences quarterly operating income?

The current quarterly operating profit of GILD is $2.44B

What is the all time high quarterly operating profit for Gilead Sciences?

Gilead Sciences all-time high quarterly operating income is $5.62B

What is Gilead Sciences quarterly operating profit year-on-year change?

Over the past year, GILD quarterly operating income has changed by -$702.00M (-22.34%)

What is Gilead Sciences TTM operating income?

The current TTM operating profit of GILD is $8.07B

What is the all time high TTM operating profit for Gilead Sciences?

Gilead Sciences all-time high TTM operating income is $22.19B

What is Gilead Sciences TTM operating profit year-on-year change?

Over the past year, GILD TTM operating income has changed by +$433.00M (+5.67%)
On this page